Pharmacokinetics of itraconazole following oral administration to normal volunteers. - Wikidata - wikimedia - TriplyDB

Pharmacokinetics of itraconazole following oral administration to normal volunteers.

Pharmacokinetics of itraconazole following oral administration to normal volunteers.

http://www.wikidata.org/entity/Q35563591

about

Systemic availability of itraconazole in lung transplantation Food interaction and steady-state pharmacokinetics of itraconazole capsules in healthy male volunteers Therapeutic drug monitoring for triazoles: A needs assessment review and recommendations from a Canadian perspective Pharmacokinetics and pharmacodynamics of antifungals in children: clinical implications Effect of itraconazole on the pharmacokinetics of prednisolone and methylprednisolone and cortisol secretion in healthy subjects Aspergillus fumigatus and aspergillosis Prediction of in vivo drug-drug interactions from in vitro data: impact of incorporating parallel pathways of drug elimination and inhibitor absorption rate constant.Limited-sampling strategy models for itraconazole and hydroxy-itraconazole based on data from a bioequivalence study Repeated-dose pharmacokinetics of an oral solution of itraconazole in infants and children.Voriconazole: a new triazole antifungal.The value of chronic suppressive therapy with itraconazole versus clotrimazole in women with recurrent vaginal candidiasis.Pharmacokinetics and safety of a 7-day administration of intravenous itraconazole followed by a 14-day administration of itraconazole oral solution in patients with hematologic malignancy Intravenous itraconazole.Itraconazole oral solution and intravenous formulations: a review of pharmacokinetics and pharmacodynamics.Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America.Itraconazole associated quadriparesis and edema: a case report Clinical safety and tolerability issues in use of triazole derivatives in management of fungal infections.Pharmacokinetic interaction between itraconazole and ceftriaxone in Yucatan miniature pigs.Pharmacokinetics of itraconazole (oral solution) in two groups of human immunodeficiency virus-infected adults with oral candidiasis.Concentrations in plasma and safety of 7 days of intravenous itraconazole followed by 2 weeks of oral itraconazole solution in patients in intensive care units.Pharmacokinetics of itraconazole and hydroxyitraconazole in healthy subjects after single and multiple doses of a novel formulation.In vitro antifungal-drug susceptibilities of mycelial and yeast forms of Penicillium marneffei isolates in Cambodia In vivo efficacy of SM-8668 (Sch 39304), a new oral triazole antifungal agent Discovery of itraconazole with broad-spectrum in vitro antienterovirus activity that targets nonstructural protein 3A.Itraconazole pharmacokinetics in patients with renal dysfunction.Efinaconazole in the treatment of onychomycosis.Dynamically simulating the interaction of midazolam and the CYP3A4 inhibitor itraconazole using individual coupled whole-body physiologically-based pharmacokinetic (WB-PBPK) models Single-dose pharmacokinetics of intravenous itraconazole and hydroxypropyl-beta-cyclodextrin in infants, children, and adolescents.Population pharmacokinetic modeling of itraconazole and hydroxyitraconazole for oral SUBA-itraconazole and sporanox capsule formulations in healthy subjects in fed and fasted states.Contribution of itraconazole metabolites to inhibition of CYP3A4 in vivo.A d-optimal designed population pharmacokinetic study of oral itraconazole in adult cystic fibrosis patients.High-dose itraconazole in the treatment of severe mycoses.Pharmacokinetics of SCH-39304 in human immunodeficiency virus-infected patients following chronic oral dosing.Antifungal agents and therapy for infants and children with invasive fungal infections: a pharmacological perspective.Voriconazole increases while itraconazole decreases plasma meloxicam concentrations.Antifungal therapeutic drug monitoring: established and emerging indications.Intrapulmonary pharmacokinetics and pharmacodynamics of itraconazole and 14-hydroxyitraconazole at steady state.Therapeutic drug monitoring (TDM) of antifungal agents: guidelines from the British Society for Medical Mycology.Opportunistic invasive fungal infections: diagnosis & clinical management.Dose-dependent pharmacokinetics of itraconazole after intravenous or oral administration to rats: intestinal first-pass effect.

P2860

Q24675285-C514889A-085B-4CCE-9DBA-78BD25F81747 Q24681178-4FB4015D-1AC2-4B0E-92C3-947D29570175 Q27009221-D938B6AE-C116-457D-995B-467D2B87019B Q27025299-AC582FF6-3005-4665-96FB-8A2644FAFAAF Q28367515-3CA950DC-A688-40DB-96AF-E1B2FEF08843 Q29617908-FA601D45-8BD7-4600-B113-AAB6B1AFBD5F Q31012256-C143EAEF-E371-421D-9289-E0D5D76FC066 Q31943628-204526B8-87ED-46EE-A154-C65126997AF0 Q33690036-25F17AA0-37EB-4300-BF0A-E9240983EAD7 Q33917339-AF52C00D-C3D7-40D0-8E6A-07D84B10BB7D Q33934112-9EB69716-F997-49C1-AD1D-78AEA3067717 Q33981794-8F40F8C1-CDAC-4184-AE4B-C4C4FEBA7C1B Q34284268-3AE488CC-859D-4A79-BEDB-344639F74A10 Q34291656-8C6C7B39-ED65-4B48-A53A-434FD3FBBF51 Q34532546-15762F54-EF69-45BC-93E7-8ACD150A2FA3 Q34825859-638A67B5-F013-4AD2-9CB0-398B3AE33A59 Q35026481-C60370A0-E052-4EC3-9F88-9DD8C2BCDC4E Q35138257-2AB51DFE-667C-4015-ABAF-905E366E3E43 Q35139090-1F141D64-FA43-41C9-961D-BBB3B70098D3 Q35139428-649B547E-68D1-4A09-907F-CAC5897B0FE2 Q35215407-9EB0B68F-909D-461E-9C06-967849C963EC Q35220825-56E87D24-5158-4679-A5D9-77D2F0465907 Q35257842-B3E60B86-1E94-4CFB-8B0E-93B63FFF879F Q35386030-D6094262-D6F6-49D9-8CC1-D33B8E847B63 Q35564534-82BAAE68-2DE7-4A3D-9228-964C42F71E1F Q35694445-680DBEF1-0F85-46FA-9A09-B8A107F12467 Q35753588-28CB629C-2510-46E8-8EFC-DE664550D281 Q35912756-B9FD5584-2156-4F79-98BC-28B8A0FDFD8C Q35960882-0529772F-8F6A-4F0D-AAC5-07B45610A589 Q36369136-BE57823E-FFAE-44E1-B525-1405C1732806 Q36388027-7F00A29F-75AB-4C55-A848-1822FBD9A12B Q36753370-1D24BB5C-9B20-4F5D-AEF3-11A41859EE21 Q36758374-08234C41-AC12-44A1-8BB5-15FA29055B5D Q36948094-DD9C99C4-5128-4A96-8DC4-6CE43E4EC4C6 Q37072046-AD15F215-04CD-4FBD-8AE6-A9435E20A705 Q37310029-97A94497-8503-4FA0-BE63-8055338A3957 Q37568382-8558BEAE-C771-4A48-83FC-7D4C0B1B2523 Q37688257-B73ADA8E-C22A-4884-86F4-42A97A994E41 Q37726198-3C8BB1BC-4560-4E6C-B113-8ADC2A6104A4 Q37733742-83C0DFB1-78DE-4A96-AC64-6CCEA9101AD7

P2860

Pharmacokinetics of itraconazole following oral administration to normal volunteers.

http://www.wikidata.org/entity/Q35563591

description

1988 nî lūn-bûn

@nan

1988年の論文

@ja

1988年論文

@yue

1988年論文

@zh-hant

1988年論文

@zh-hk

1988年論文

@zh-mo

1988年論文

@zh-tw

1988年论文

@wuu

1988年论文

@zh

1988年论文

@zh-cn

name

Pharmacokinetics of itraconazole following oral administration to normal volunteers.

@ast

Pharmacokinetics of itraconazole following oral administration to normal volunteers.

@en

type

label

Pharmacokinetics of itraconazole following oral administration to normal volunteers.

@ast

Pharmacokinetics of itraconazole following oral administration to normal volunteers.

@en

prefLabel

Pharmacokinetics of itraconazole following oral administration to normal volunteers.

@ast

Pharmacokinetics of itraconazole following oral administration to normal volunteers.

@en

P1433

Q35563591-3FCA0762-BC09-4DB1-B3B0-1B286C696C3A

P1476

Q35563591-0F366DF8-ECC1-44B8-944B-83B8BC5E4797

P2093

Q35563591-1AFA2444-8C84-4B46-9AE8-F377E4E17D56

Q35563591-89115EA1-4E4F-4BA8-8EB8-D1767305A875

Q35563591-932228E6-C034-45FB-B34F-CB02F5B048BF

Q35563591-B432294F-ECCA-428C-ADCC-0F8650BF3A64

Q35563591-DB7218D1-41C1-4DFC-BD6C-5B8037ACFF72

Q35563591-F7015FA8-ECC5-408F-903F-C352FB93B6A5

P2860

Q35563591-564E34EA-32A2-4DCC-B7E8-F05625D7FF97

Q35563591-790DF48F-1CCC-40B8-B9DE-E1D831355860

Q35563591-8A97C598-3B0B-471D-8484-E8D6ADB27C87

P304

Q35563591-9053328B-3679-433C-BCF6-F9358B107479

P31

Q35563591-D0D4FFE5-DED6-460B-97F8-D6D0C41B340C

P356

Q35563591-16ADDF9C-6B66-4F10-AB34-25450381B5A0

P407

Q35563591-8728A7EC-F6F0-4D68-9287-C32FB2BE9007

P433

Q35563591-EDC3D5B5-F494-407D-901B-6E6433CEF757

P478

Q35563591-9761719A-791C-4A3F-8693-C3E51493C2FC

P577

Q35563591-E1C6F421-EAAC-4E26-9457-26E2FF29640C

P698

Q35563591-D8995703-9ADA-4EE0-A001-1FD72B96BC2F

P932

Q35563591-9D2190DD-2AEF-4610-BE74-E0DDDE0807BC

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Pharmacokinetics of itraconazole following oral administration to normal volunteers.

@en

P2093

J G Kuhn

http://www.w3.org/2001/XMLSchema#string

J R Graybill

http://www.w3.org/2001/XMLSchema#string

M G Rinaldi

http://www.w3.org/2001/XMLSchema#string

R Fetchick

http://www.w3.org/2001/XMLSchema#string

R Woestenborghs

http://www.w3.org/2001/XMLSchema#string

T C Hardin

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacokinetics and dose proportionality of ketoconazole in normal volunteers

Itraconazole, a new triazole that is orally active in aspergillosis.

Itraconazole pharmacokinetics in the female genital tract: plasma and tissue levels in patients undergoing hysterectomy after a single dose of 200 mg itraconazole.

P304

1310-1313

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.32.9.1310

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

32

http://www.w3.org/2001/XMLSchema#string

P577

1988-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

2848442

http://www.w3.org/2001/XMLSchema#string

P932

175857

http://www.w3.org/2001/XMLSchema#string